Home » Topics » BioWorld Science

BioWorld Science
RSS

Morphic Therapeutic identifies new MAdCAM antagonists

Nov. 5, 2019

Japanese investigators patent CRF1 and CRF2 dual receptor antagonists

Nov. 5, 2019

Unum shifts focus to solid tumor programs

Nov. 5, 2019

Neuropore Therapies synthesizes PI3K-AKT-mTOR pathway inhibitors

Nov. 5, 2019

Lycera describes MAP4K1 inhibitors

Nov. 5, 2019

Terns patents new MAP3K5 inhibitors

Nov. 5, 2019

MedImmune initiates first-in-human study of MEDI-5395 with durvalumab in advanced solid tumors

Nov. 5, 2019

Clarivate Analytics introduces next-gen drug R&D platform: Cortellis Drug Discovery Intelligence

Nov. 5, 2019

AstraZeneca initiates phase I/IIa study of AZD-7648 alone and in combination for advanced cancers

Nov. 5, 2019

Promising preclinical results presented for DTX-701, a gene therapy for Wilson disease

Nov. 5, 2019

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...